Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Pozdnyakov, Stanislav O
MEMO, NCT06834490: Safety and Efficacy of Sequential Treatment with Mexidol® in Patients with Chronic Cerebral Ischemia	Completed	3	318	RoW	Mexidol, Ethylmethylhydroxypyridine Succinate, Placebo	Pharmasoft	Chronic Cerebral Ischemia	12/20	12/20
NCT06292351: DMB-I in the Treatment of Alzheimer Type Dementia	Completed	2	133	RoW	DMB-I (Dimebon), Placebo	Bigespas LTD	Alzheimer Disease, Dementia of Alzheimer Type	01/25	01/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Pozdnyakov, Stanislav O
MEMO, NCT06834490: Safety and Efficacy of Sequential Treatment with Mexidol® in Patients with Chronic Cerebral Ischemia	Completed	3	318	RoW	Mexidol, Ethylmethylhydroxypyridine Succinate, Placebo	Pharmasoft	Chronic Cerebral Ischemia	12/20	12/20
NCT06292351: DMB-I in the Treatment of Alzheimer Type Dementia	Completed	2	133	RoW	DMB-I (Dimebon), Placebo	Bigespas LTD	Alzheimer Disease, Dementia of Alzheimer Type	01/25	01/25